PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
YMAX.AX vs. DRUG.AX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

YMAX.AX vs. DRUG.AX

Last updated Jul 18, 2026
Documentation

YMAX.AX (Betashares Australian Top 20 Equities Yield Maximiser Complex ETF) and DRUG.AX (Betashares Global Healthcare Currency Hedged ETF) are both exchange-traded funds - YMAX.AX is a Global Equities fund actively managed by BetaShares, while DRUG.AX is a Health & Biotech Equities fund tracking the Nasdaq Global ex-Australia Healthcare Hedged AUD Index. YMAX.AX is actively managed, while DRUG.AX is passively managed. Over the past 5 years, YMAX.AX returned 4.61%/yr vs 4.03%/yr for DRUG.AX. At a 0.37 correlation, their price movements are largely independent.

Performance

YMAX.AX vs. DRUG.AX - Performance Comparison

The chart below illustrates the hypothetical performance of a A$10,000 investment in Betashares Australian Top 20 Equities Yield Maximiser Complex ETF (YMAX.AX) and Betashares Global Healthcare Currency Hedged ETF (DRUG.AX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, YMAX.AX achieves a 1.88% return, which is significantly higher than DRUG.AX's 1.49% return.

YMAX.AX

1D
0.40%
1M
-0.06%
6M
2.56%
YTD
1.88%
1Y
1.32%
3Y*
5.87%
5Y*
4.61%
10Y*
5.23%

DRUG.AX

1D
1.89%
1M
5.32%
6M
0.23%
YTD
1.49%
1Y
17.07%
3Y*
6.21%
5Y*
4.03%
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

YMAX.AX vs. DRUG.AX - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
YMAX.AX
Betashares Australian Top 20 Equities Yield Maximiser Complex ETF		1.88%2.55%5.33%10.63%1.82%15.02%-2.73%14.44%-5.59%4.13%
DRUG.AX
Betashares Global Healthcare Currency Hedged ETF		1.49%11.83%1.82%0.76%-3.68%23.60%4.75%21.95%2.11%18.34%

Correlation

The correlation between YMAX.AX and DRUG.AX is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.32

Correlation (3Y)
Calculated over the trailing 3-year period

0.33

Correlation (5Y)
Calculated over the trailing 5-year period

0.39

Correlation (All Time)
Calculated using the full available price history since Aug 4, 2016

0.37

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Betashares Australian Top 20 Equities Yield Maximiser Complex ETF

Betashares Global Healthcare Currency Hedged ETF

Often compared with YMAX.AX:
YMAX.AX vs. A200.AXYMAX.AX vs. ARMR.AXYMAX.AX vs. CORE.AXYMAX.AX vs. DHHF.AXYMAX.AX vs. ESGI.AXYMAX.AX vs. ESTX.AXYMAX.AX vs. EX20.AX
Often compared with DRUG.AX:
DRUG.AX vs. EX20.AXDRUG.AX vs. FOOD.AXDRUG.AX vs. FUEL.AXDRUG.AX vs. A200.AXDRUG.AX vs. AAA.AXDRUG.AX vs. ARMR.AXDRUG.AX vs. BNKS.AX

Return for Risk

YMAX.AX vs. DRUG.AX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
YMAX.AX
YMAX.AX Risk / Return Rank: 1212
Overall Rank
YMAX.AX Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
YMAX.AX Sortino Ratio Rank: 1111
Sortino Ratio Rank
YMAX.AX Omega Ratio Rank: 1111
Omega Ratio Rank
YMAX.AX Calmar Ratio Rank: 1313
Calmar Ratio Rank
YMAX.AX Martin Ratio Rank: 1212
Martin Ratio Rank
DRUG.AX
DRUG.AX Risk / Return Rank: 3838
Overall Rank
DRUG.AX Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
DRUG.AX Sortino Ratio Rank: 4343
Sortino Ratio Rank
DRUG.AX Omega Ratio Rank: 3838
Omega Ratio Rank
DRUG.AX Calmar Ratio Rank: 3939
Calmar Ratio Rank
DRUG.AX Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

YMAX.AX vs. DRUG.AX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Betashares Australian Top 20 Equities Yield Maximiser Complex ETF (YMAX.AX) and Betashares Global Healthcare Currency Hedged ETF (DRUG.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

YMAX.AXDRUG.AXDifference
Sharpe ratioReturn per unit of total volatility
0.12
1.07

-0.95

Sortino ratioReturn per unit of downside risk
0.24
1.70

-1.46

Omega ratioGain probability vs. loss probability

1.03

1.20

-0.17

Calmar ratioReturn relative to maximum drawdown

0.19

1.56

-1.37

Martin ratioReturn relative to average drawdown

0.37

3.72

-3.35

YMAX.AX vs. DRUG.AX - Sharpe Ratio Comparison

The current YMAX.AX Sharpe Ratio is 0.12, which is lower than the DRUG.AX Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of YMAX.AX and DRUG.AX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

YMAX.AX vs. DRUG.AX - Drawdown Comparison

The maximum YMAX.AX drawdown since its inception was -31.97%, which is greater than DRUG.AX's maximum drawdown of -26.79%. Use the drawdown chart below to compare losses from any high point for YMAX.AX and DRUG.AX.

Loading charts...

Drawdown Indicators

YMAX.AXDRUG.AXDifference

Max Drawdown

Largest peak-to-trough decline

-31.97%

-26.79%

-5.18%

Max Drawdown (1Y)

Largest decline over 1 year

-6.80%

-10.69%

+3.89%

Max Drawdown (3Y)

Largest decline over 3 years

-11.90%

-20.63%

+8.73%

Max Drawdown (5Y)

Largest decline over 5 years

-12.73%

-20.63%

+7.90%

Max Drawdown (10Y)

Largest decline over 10 years

-31.97%

—

—

Current Drawdown

Current decline from peak

-2.16%

-2.61%

+0.45%

Average Drawdown

Average peak-to-trough decline

-5.20%

-5.17%

-0.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.55%

4.52%

-0.97%

Volatility

YMAX.AX vs. DRUG.AX - Volatility Comparison

The current volatility for Betashares Australian Top 20 Equities Yield Maximiser Complex ETF (YMAX.AX) is 2.69%, while Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) has a volatility of 6.29%. This indicates that YMAX.AX experiences smaller price fluctuations and is considered to be less risky than DRUG.AX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

YMAX.AXDRUG.AXDifference

Volatility (1M)

Calculated over the trailing 1-month period

2.69%

6.29%

-3.60%

Volatility (6M)

Calculated over the trailing 6-month period

8.76%

11.71%

-2.95%

Volatility (1Y)

Calculated over the trailing 1-year period

11.27%

15.65%

-4.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

11.41%

14.95%

-3.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

13.69%

16.17%

-2.48%

Dividends

YMAX.AX vs. DRUG.AX - Dividend Comparison

YMAX.AX's dividend yield for the trailing twelve months is around 4.52%, more than DRUG.AX's 3.63% yield.

PositionTTM20252024202320222021202020192018201720162015
DRUG.AX
Betashares Global Healthcare Currency Hedged ETF		3.63%0.00%2.84%0.00%0.00%4.49%0.62%0.28%3.37%0.00%0.00%0.00%
YMAX.AX
Betashares Australian Top 20 Equities Yield Maximiser Complex ETF		4.52%8.05%3.52%6.15%7.34%8.58%8.18%9.01%7.13%6.46%7.18%6.73%

Frequently Asked Questions

YMAX.AX and DRUG.AX have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

YMAX.AX is categorized as Global Equities, while DRUG.AX is Health & Biotech Equities.

Portfolio Optimizer

Find the right allocation for YMAX.AX and DRUG.AX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer